MKI67 and neoplasm: Moreover, the number of Ki-67-positive tumour cells and that of tumour-infiltrating not only CD11c+ and OX-62+ cells but also CD4+ and CD8+ cells were compared among the four groups via one-way ANOVA using Tukey’s multiple-comparison test.